Sato, K.; Naganuma, A.; Nagashima, T.; Arai, Y.; Mikami, Y.; Nakajima, Y.; Kanayama, Y.; Murakami, T.; Uehara, S.; Uehara, D.;
et al. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases. Biomedicines 2023, 11, 1445.
https://doi.org/10.3390/biomedicines11051445
AMA Style
Sato K, Naganuma A, Nagashima T, Arai Y, Mikami Y, Nakajima Y, Kanayama Y, Murakami T, Uehara S, Uehara D,
et al. A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases. Biomedicines. 2023; 11(5):1445.
https://doi.org/10.3390/biomedicines11051445
Chicago/Turabian Style
Sato, Ken, Atsushi Naganuma, Tamon Nagashima, Yosuke Arai, Yuka Mikami, Yuka Nakajima, Yuki Kanayama, Tatsuma Murakami, Sanae Uehara, Daisuke Uehara,
and et al. 2023. "A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases" Biomedicines 11, no. 5: 1445.
https://doi.org/10.3390/biomedicines11051445
APA Style
Sato, K., Naganuma, A., Nagashima, T., Arai, Y., Mikami, Y., Nakajima, Y., Kanayama, Y., Murakami, T., Uehara, S., Uehara, D., Yamazaki, Y., Murase, T., Nakamura, T., & Uraoka, T.
(2023). A Newly Developed Method-Based Xanthine Oxidoreductase Activities in Various Human Liver Diseases. Biomedicines, 11(5), 1445.
https://doi.org/10.3390/biomedicines11051445